Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Rådgivning › fagfællebedømt
Standard
Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 : (Scientific Opinion). / EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA).
I: E F S A Journal, Bind 14, Nr. 10, 4587, 20.10.2016.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Rådgivning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
T2 - (Scientific Opinion)
AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
AU - Sjödin, Anders Mikael
N1 - EFSA 2016 4587
PY - 2016/10/20
Y1 - 2016/10/20
N2 - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium andcontribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effectrelationship has been established between the dietary intake of calcium and contribution to the normal development of bones.
AB - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium andcontribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effectrelationship has been established between the dietary intake of calcium and contribution to the normal development of bones.
KW - Faculty of Science
KW - Calcium
KW - Infants
KW - Children
KW - Bones
KW - Health claims
U2 - 10.2903/j.efsa.2016.4587
DO - 10.2903/j.efsa.2016.4587
M3 - Journal article
VL - 14
JO - E F S A Journal
JF - E F S A Journal
SN - 1831-4732
IS - 10
M1 - 4587
ER -
ID: 188268375